Related Experiment Video
Updated: Jul 25, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Interstitial Lung Disease in Neonates: A Long Road Is Being Paved
N Kh Gabitova1,2, I N Cherezova1,2, Ahmed Arafat1,2,3
1Department of Pediatrics, School of Medicine, Kazan State Medical University, 420012 Kazan, Russia.
Insights
Interstitial lung disease (ILD) in neonates is challenging to diagnose. This study reports rare cases of fibrosing alveolitis and desquamative interstitial pneumonitis (DIP) in neonates, highlighting diagnostic challenges and potential risk factors.
Area of Science:
- Neonatal Pulmonology
- Pediatric Pathology
- Interstitial Lung Diseases
Background:
- Interstitial lung disease (ILD) encompasses a heterogeneous group of lung conditions damaging the alveolar epithelium, parenchyma, and capillaries.
- Diagnosis, classification, and treatment of ILD, particularly in neonates, present significant challenges due to invasive or inaccessible diagnostic methods.
- Existing ILD classifications have evolved for adults and children, but a standardized approach for neonates remains elusive, contributing to high morbidity and mortality.
Observation:
- This report details two rare cases of neonatal ILD: fibrosing alveolitis and desquamative interstitial pneumonitis (DIP).
- Histopathological examination of lung biopsies confirmed fibrosing alveolitis (mononuclear cells, thickened alveolar walls) and DIP (desquamation of mononuclear cells) in neonates.
- These diagnoses, typically associated with adulthood, were confirmed in neonates, underscoring the need for broader diagnostic considerations.
Findings:
- Fibrosing alveolitis and desquamative interstitial pneumonitis (DIP) can occur in neonates, despite being rare and often considered adult conditions.
- Histopathological analysis is crucial for confirming diagnoses of ILD in neonates when clinical presentation is atypical.
- Prenatal and maternal conditions may be potential risk factors for developing ILD in neonates, warranting further investigation.
Implications:
- The findings challenge the notion that certain ILDs are exclusive to adults, emphasizing the importance of considering these diagnoses in neonates.
- Establishing consensus guidelines for neonatal ILD classification and diagnosis is critical for improving patient outcomes.
- Further research is needed to validate the role of prenatal and maternal factors as risk factors for neonatal ILD.
Abstract:
Background: Interstitial lung disease (ILD) is one of the most difficult conditions in pulmonology due to difficulties in diagnosing, classifying, and treating this condition. They require invasive approaches to diagnose (e.g., lung biopsy), non-applicable methods (e.g., lung function tests in newborns), or potentially non-accessible methods (e.g., genetic testing in not-well-equipped facilities, and several weeks are required for results to be announced). They represent a heterogeneous group of diseases in which the alveolar epithelium, parenchyma, and capillaries of the lungs are damaged, which leads to changes in the pulmonary interstitium, proliferation of connective tissue, and thickening of the alveolar-capillary membranes and alveolar septa. These changes are accompanied by impaired oxygen diffusion, progressive respiratory failure, and radiographic signs of bilateral dissemination. Although adult and child classifications for ILD have evolved over the years, classification for ILD in neonates remains a challenge. Case presentation: Here we discuss ILD in neonates briefly, and report two rare cases of ILD (a male white neonate, two-day-old with fibrosing alveolitis, and another male white neonate, one-day old with desquamative interstitial pneumonitis), with these diagnoses initially thought to be presented only in adulthood. Lung biopsy and histopathological findings of the two neonates have shown mononuclear cells in the alveolar spaces, and thickening of the alveolar walls confirmed the diagnosis of fibrosing alveolitis in one neonate, and desquamation of the large mononuclear cells in the intra-alveolar space in the other neonate, with the diagnosis of desquamative interstitial pneumonitis being confirmed. Interstitial lung disease lacks a consensus guideline on classification and diagnosis in neonates, rendering it one of the greatest challenges to pediatricians and neonatologists with remarkable morbidity and mortality rates. Conclusions: Fibrosing alveolitis and desquamative interstitial pneumonitis (DIP) are not adult-only conditions, although rare in neonates, histopathological examination and clinical practice can confirm the diagnosis. Based on our clinical practice, prenatal and maternal conditions may serve as potential risk factors for developing IDL in neonates, and further studies are needed to prove this hypothesis.
Related Concept Videos
Breathing
Pulmonary Cycle: Exhalation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

